160 related articles for article (PubMed ID: 16023828)
1. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder.
Pike JL; Irwin MR
Brain Behav Immun; 2006 Mar; 20(2):169-74. PubMed ID: 16023828
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory markers and sleep disturbance in major depression.
Motivala SJ; Sarfatti A; Olmos L; Irwin MR
Psychosom Med; 2005; 67(2):187-94. PubMed ID: 15784782
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the immune system activity in Iranian patients with Major Depression Disorder (MDD).
Farid Hosseini R; Jabbari Azad F; Talaee A; Miri S; Mokhber N; Farid Hosseini F; Esmaeili H; Mahmoudi M; Rafatpanah H; Mohammadi M
Iran J Immunol; 2007 Mar; 4(1):38-43. PubMed ID: 17652842
[TBL] [Abstract][Full Text] [Related]
4. Decreased TNF-alpha and NK activity in obsessive-compulsive disorder.
Denys D; Fluitman S; Kavelaars A; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2004 Aug; 29(7):945-52. PubMed ID: 15177711
[TBL] [Abstract][Full Text] [Related]
5. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subsets and lymphokine production in patients with melancholic versus nonmelancholic depression.
Schlatter J; Ortuño F; Cervera-Enguix S
Psychiatry Res; 2004 Oct; 128(3):259-65. PubMed ID: 15541783
[TBL] [Abstract][Full Text] [Related]
7. Major depression and immunity in alcohol-dependent persons.
Schleifer SJ; Keller SE; Czaja S
Brain Behav Immun; 2006 Jan; 20(1):80-91. PubMed ID: 16039825
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder.
Soygur H; Palaoglu O; Akarsu ES; Cankurtaran ES; Ozalp E; Turhan L; Ayhan IH
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1242-7. PubMed ID: 17587477
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell cytotoxity and course of illness in depressed mood.
Reynaert C; Janne P; Jacques D; Tordeurs D; Zdanowicz N
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S132-4. PubMed ID: 21057421
[TBL] [Abstract][Full Text] [Related]
10. Low plasma levels of oxygenated carotenoids in patients with coronary artery disease.
Lidebjer C; Leanderson P; Ernerudh J; Jonasson L
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):448-56. PubMed ID: 17134954
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers in late-life depression: results from a population-based study.
Bremmer MA; Beekman AT; Deeg DJ; Penninx BW; Dik MG; Hack CE; Hoogendijk WJ
J Affect Disord; 2008 Mar; 106(3):249-55. PubMed ID: 17716746
[TBL] [Abstract][Full Text] [Related]
12. Immune-endocrine host response to endotoxin in major depression.
Vedder H; Schreiber W; Schuld A; Kainz M; Lauer CJ; Krieg JC; Holsboer F; Pollmächer T
J Psychiatr Res; 2007; 41(3-4):280-9. PubMed ID: 17045296
[TBL] [Abstract][Full Text] [Related]
13. Natural Killer T cells in patients with major depressive disorder.
Park EJ; Lee JH; Chae JH; Lee KH; Han SI; Jeon YW
Psychiatry Res; 2006 Nov; 144(2-3):237-9. PubMed ID: 17027089
[TBL] [Abstract][Full Text] [Related]
14. Potential psychosocial mechanisms linking depression to immune function in elderly subjects.
Bouhuys AL; Flentge F; Oldehinkel AJ; van den Berg MD
Psychiatry Res; 2004 Jul; 127(3):237-45. PubMed ID: 15296823
[TBL] [Abstract][Full Text] [Related]
15. Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity.
Greenfeld K; Avraham R; Benish M; Goldfarb Y; Rosenne E; Shapira Y; Rudich T; Ben-Eliyahu S
Brain Behav Immun; 2007 May; 21(4):503-13. PubMed ID: 17293081
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
[TBL] [Abstract][Full Text] [Related]
17. Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.
Wichers MC; Kenis G; Leue C; Koek G; Robaeys G; Maes M
Biol Psychiatry; 2006 Jul; 60(1):77-9. PubMed ID: 16487941
[TBL] [Abstract][Full Text] [Related]
18. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids.
Dinan T; Siggins L; Scully P; O'Brien S; Ross P; Stanton C
J Psychiatr Res; 2009 Jan; 43(4):471-6. PubMed ID: 18640689
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers in depression.
Dinan TG
Curr Opin Psychiatry; 2009 Jan; 22(1):32-6. PubMed ID: 19122532
[TBL] [Abstract][Full Text] [Related]
20. Immunity in adolescents with major depression.
Schleifer SJ; Bartlett JA; Keller SE; Eckholdt HM; Shiflett SC; Delaney BR
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1054-60. PubMed ID: 12218426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
